Completed PHASE3 INTERVENTIONAL 2-arm NCT01617343

The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients

The HEP-OKS Pilot Study - a Randomized Controlled Trial of Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients

Sponsor: German Research Foundation

Conditions Cerebral Stroke Spatial Neglect

Interventions hemifield eye patching (HEP) + optokinetic stimulation (OKS)

Updated 6 times since 2017 Last updated: Apr 7, 2014 Started: Aug 31, 2012 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cerebral Stroke and Spatial Neglect, this trial is completed. The trial is conducted by German Research Foundation and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Research Foundation
University of Luebeck

Data source: University of Luebeck

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lübeck, Germany